Proof LGBTQs Are Mentally Ill: Southern Research-Bionetix Collaboration Seeks Novel Cancer Drug That Targets a Genetic Switch

Southern Research and Bionetix Inc., a South Korea-based biotech firm, have signed a research and license agreement to develop a new anti-cancer drug that affects a key genetic switch associated with suppression and regulation of the growth of certain types of cancer.